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Abstract
Background: Policymakers and healthcare stakeholders are increasingly seeking evidence to inform the policymaking
process, and often use existing or commissioned systematic reviews to inform decisions. However, the methodologies
that make systematic reviews authoritative take time, typically 1 to 2 years to complete. Outside the traditional SR
timeline, “rapid reviews” have emerged as an efficient tool to get evidence to decision-makers more quickly. However,
the use of rapid reviews does present challenges. To date, there has been limited published empirical information
about this approach to compiling evidence. Thus, it remains a poorly understood and ill-defined set of diverse
methodologies with various labels. In recent years, the need to further explore rapid review methods, characteristics,
and their use has been recognized by a growing network of healthcare researchers, policymakers, and organizations,
several with ties to Cochrane, which is recognized as representing an international gold standard for high-quality,
systematic reviews.
Purpose: In this commentary, we introduce the newly established Cochrane Rapid Reviews Methods Group developed
to play a leading role in guiding the production of rapid reviews given they are increasingly employed as a research
synthesis tool to support timely evidence-informed decision-making. We discuss how the group was formed and
outline the group’s structure and remit. We also discuss the need to establish a more robust evidence base for rapid
reviews in the published literature, and the importance of promoting registration of rapid review protocols in an effort
to promote efficiency and transparency in research.
Conclusion: As with standard systematic reviews, the core principles of evidence-based synthesis should apply to
rapid reviews in order to minimize bias to the extent possible. The Cochrane Rapid Reviews Methods Group will serve
to establish a network of rapid review stakeholders and provide a forum for discussion and training. By facilitating
exchange, the group will strive to conduct research to advance the methods of rapid reviews.
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Background
Cochrane is an international non-profit organization that
is the world’s largest producer of high-quality systematic
reviews (SRs) of effectiveness with over 37,000 contribu-
tors from more than 130 countries. This work is managed
by 53 review groups that span a range of health topics. A
SR typically takes at least 12 months to conduct. However,
the SR process can range anywhere from 6 months to
2 years [1–3]. Ensuring the methodological rigor of the
SR process is labor-intense. As a consequence, SRs often
do not meet the time-sensitive needs of some users,
notably healthcare policymakers. A more timely process
is required to respond to pressured decision-making. The
international knowledge synthesis community has
responded by developing rapid reviews (RRs), described
as members of the knowledge syntheses family [4]. RRs
are thought to be more systematic than narrative reviews,
use abbreviated SR methods, and are completed within
shorter timeframes ranging from a few weeks to usually
no more than 6 months. RRs can take different forms
along a spectrum of products with various labels such as
rapid evidence synthesis, rapid evidence assessment, or
rapid evidence summary to name a few. Common to these
products is that they require methodological shortcuts
that may increase the uncertainty of findings.
Policymakers are using RRs in their day-to-day decision-
making, and RRs have been shown to be influential on the
development of health policy [2, 5–10]. Further, there are
strong signals of increased use among researchers and
other healthcare stakeholders [1, 2, 10–13]. The existence
of at least 29 international organizations that conduct RRs
has been formally documented [13], and anecdotally we
know of more. Further, due to the increased interest of
public authorities and clinicians, both the World Health
Organization (WHO) and the Guidelines-International-
Network (G-I-N) have undertaken methods for developing
guidelines in an accelerated timeframe using RR methods
to inform recommendations [14–16].
While the concept RR is not novel, it remains a poorly
understood and as yet ill-defined set of diverse methodolo-
gies supported by a paucity of published, available scientific
literature. For example, there is no universally accepted def-
inition of RR. Of the definitions that do exist [2, 17–21],
not all address variances in types of RRs produced across
different contexts, and most appear to be driven by a
particular mandate or scope of the entities producing and
commissioning them. Although we consider the main
difference between SRs and RRs to be methodological
shortcuts, some would argue that a SR delivered within
accelerated timelines should be considered a RR. The
challenge is that with no clear or formal definition of RR,
this issue has yet to be addressed. It may be the case that
when doing a SR rapidly, some decisions may be made
under pressure including use of methodological shortcuts
in order to meet a deadline. However, it is unclear how
often this might occur and how much the potential impact
is on the final products. Another factor to consider is
whether a SR was conducted quickly because the scope was
narrow and/or the existing literature base to review was
minimal compared with a SR that was sizeable but with
additional resources allocated to meet a short timeline.
Thus, further methodological research is needed to inform
this discussion.
A minimum set of consensus-based criteria as to what
constitutes a RR will be instrumental in guiding future
research discussions and is needed to improve trans-
parency and understanding by end-users. Some investiga-
tions have examined the characteristics of RRs to better
understand what methods are being employed and to
what extent they resemble similar conduct stages of a SR
[1, 10, 11, 22–25]. However, little is known about when to
undertake RRs, whether they provide similar results to
SRs, and the impact of methodological shortcuts (relative
to the SR process) on the validity of results and subse-
quent conclusions. Further, RRs are challenging to identify
in that once produced or commissioned by organizations,
they are often not published in peer-reviewed journals. Of
those that are published, unless the terms “rapid (system-
atic) review” and “rapid evidence assessment or synthesis”
are in the title or abstract, it can be difficult to classify
such studies given the various synonyms for RR. None of
the mainstream biomedical bibliographic databases such
as MEDLINE®/PubMed® currently employ a specific
indexing term for the RR publication type. It is important
to note that the methodological choices when doing a RR
in order to meet the specific needs of a commissioning
body within a short timeframe might subsequently restrict
the scope, usefulness, and reusability of the review. As
with any report, the perceived quality of a RR may impede
publication in a peer-reviewed journal.
In spite of their challenges, the speed with which RRs
are gaining prominence and are being incorporated into
urgent decision-making underscores the need to further
explore their methods, characteristics, and use. While
RR producers must answer the time-sensitive needs of
the healthcare decision-makers they serve, they must
simultaneously ensure that the scientific imperative of
methodological rigor is satisfied. In order to adequately
address this inherent tension, a need for methodological
research and development of standards has been identi-
fied [26].
For these reasons, and with interest from within the
SR community, we have established a Cochrane methods
group to better inform “rapid review” methodology that
will serve the Cochrane membership and beyond and
will provide an opportunity for Cochrane to position
itself as a leader in this emerging field of synthesis, akin
to the influence it has had on SRs.
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The role and function of the Cochrane Rapid Reviews
Methods Group
The notion of developing a RR methods group within
Cochrane germinated from the 2013 Cochrane Colloquium
in Quebec City, Canada, when a core of the current conve-
nors planned and facilitated an information-sharing session
open to interested participants. The colloquium also in-
cluded an oral session that featured a series of focused pre-
sentations on RRs. These two colloquium events, which
drew much attention, indicated there was interest in RR
methods and their applications, particularly as they relate
to health policy and decision-making. Several themes were
raised including reasons that would constitute why RRs are
undertaken rather than traditional SRs. Further, various
organizations in attendance at the open discussion contrib-
uted information on their respective RR program method-
ology, including how they define “rapid review”, types of
reports produced, and specific steps involved in topic
selection, protocol development, report production, and
report submission and dissemination. From these explora-
tory events, an informal network of researchers and health-
care organizations involved with and, or interested in, RRs
materialized. Over the next 2 years, additional exploratory
discussions were held, namely at the Canadian Cochrane
Symposium (2014) and Evidence Live in the UK (2015) to
further assess interest and support for a methods group.
These efforts culminated in the registration of the
Cochrane Rapid Reviews Methods Group in October 2015,
now the newest of the 17 global Cochrane Method Groups
for those with interest and expertise in the science of SRs.
At the present time, the role of Cochrane Rapid Reviews
Methods Group is to actively involve a large community
of relevant stakeholders to engage in methods innovations
and development in rapid evidence synthesis. Specifically,
our group will serve as a discussion forum; be involved in
RR methods research, development, and evaluation; lead
RR methods guidance and handbooks; and produce
standards for the conduct and reporting of RRs. As the
group strives to develop a valued network for people to
share and develop ideas in relation to RRs, it will be
important that it maintain a database of RR publications
and of persons with interest in RRs, and to establish
linkages with other organizations and potential commis-
sioners or end-users of RRs. This Cochrane group will also
endeavor to deliver training through Cochrane events and
elsewhere. Whether a RR producer, commissioner, funder,
or SR methodologist, our hope is to encourage you to join
and participate in this important work.
Presently, the Cochrane Rapid Reviews Methods Group
is comprised of five co-convenors from Canada, the USA,
and Austria. Although unfunded, the group is sustained
through institutional in-kind support provided by the
Ottawa Hospital Research Institute (OHRI), Cochrane
Austria, the Center for Evidence-based Policy at Oregon
Health & Science University (OHSU), and the Canadian
Agency for Drugs and Technologies in Health (CADTH).
Virtual co-administration is provided by the Ottawa
Methods Centre based at OHRI, and Cochrane Austria. As
we launch the start of the group, we are encouraged by our
current membership, which consists of over 250 individuals
from 30 countries. For further information about joining
our membership, or to learn more about the group, visit
the Cochrane Rapid Reviews Methods Group website at
http://methods.cochrane.org/rapidreviews/welcome.
Establishing a more robust evidence base for rapid
reviews
We recognize that, to date, a limited number of RRs have
been published in the peer-reviewed literature, with most
reports found by searching the gray literature space.
Moreover, even fewer studies specific to RR methods
studies have been published. However, since the start of
2015, there has been an increase in the number of relevant
references aiming to advance the knowledge of RRs in-
cluding aspects of conduct and the perception of stake-
holders. The willingness of Systematic Reviews to publish
RR-related articles [2, 4, 13, 22, 25–33] has provided an
important platform for disseminating developments to
facilitate timely production of RRs. We are encouraged to
see more published contributions to the field of RRs and
look forward to seeing additional key studies published in
Systematic Reviews and elsewhere, and how they may con-
tribute to our unfolding work as a Cochrane methods group.
Promoting efficiencies
At a time of rising healthcare costs, restricted research
funding, and the need to reduce waste in research, RRs are
on the radar as a useful tool helping to inform evidence-
based healthcare decision-making. In order to reduce the
risk of unplanned duplication of RRs, the Cochrane Rapid
Reviews Methods Group encourages all producers and
commissioners of RRs to consider registering their RR
protocol with PROSPERO, the international prospective
register of SRs, including Cochrane reviews [34]. To date,
only a small fraction of PROSPERO’s more than 10,000
records are registered as “rapid”, according to listed titles
and abstracts. One reason could be that the notion of
registration is still unknown to many researchers. Another
might be that RR is not yet an official PROSPERO category
of “review type”, although currently under consideration.
Nonetheless, RRs are eligible if they meet PROSPERO’s
eligibility criteria (http://www.crd.york.ac.uk/PROSPERO/).
Registration would allow those commissioning or planning
RRs to identify whether any RRs on a given topic are
underway, to avoid unintended duplication of effort and to
increase transparency of methods. Therefore, the Cochrane
Rapid Reviews Methods Group will actively promote regis-
tration as part of its remit. Cochrane’s involvement with
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RRs is currently being explored but is yet to be determined.
As a result, although RRs are not formally incorporated
into Cochrane, the Cochrane Rapid Reviews Methods
Group aims, at this stage, to connect with the broader re-
search synthesis community in order to make RR methods
development more visible internationally.
Conclusions
Although important differences exist between developing a
standard SR and RR, it will be important that the core prin-
ciples of evidence-based synthesis apply to RRs to minimize
bias to the extent possible given accelerated timeframes,
applying a transparent process, and use of explicit methods.
Therefore, establishment of a methods group such as this
one will be important in guiding methods research in order
to mitigate the challenges that plague RRs, in spite of the
purpose they serve.
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